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Background: Apnea of prematurity (AOP) is nearly univer-
sal among very preterm infants, but neither the apnea burden 
nor its clinical associations have been systematically studied in 
a large consecutive cohort.
Methods: We analyzed continuous bedside monitor chest 
impedance and electrocardiographic waveforms and oxygen 
saturation data collected on all neonatal intensive care unit 
(NICU) patients <35 wk gestation from 2009 to 2014 (n = 1,211; 
>50 infant-years of data). Apneas, with bradycardia and desatu-
ration (ABDs), defined as central apnea ≥10 s associated with 
both bradycardia <100 bpm and oxygen desaturation <80%, 
were identified using a validated automated algorithm.
results: Number and duration of apnea events decreased 
with increasing gestational age (GA) and postmenstrual age 
(PMA). ABDs were more frequent in infants <31 wk GA at birth 
but were not more frequent in those with severe retinopathy 
of prematurity (ROP), bronchopulmonary dysplasia (BPD), or 
severe intraventricular hemorrhage (IVH) after accounting for 
GA. In the day before diagnosis of late-onset septicemia and 
necrotizing enterocolitis, ABD events were increased in some 
infants. Many infants continued to experience short ABD 
events in the week prior to discharge home.
conclusion: Frequency of apnea events is a function of GA 
and PMA in infants born preterm, and increased apnea is asso-
ciated with acute but not with chronic pathologic conditions.
apnea of prematurity (AOP) reflects immaturity of brain-stem and peripheral chemoreceptors and occurs in essen-
tially all infants born at <28 wk gestation and many of those 
born between 28–34 wk (1–4). AOP is commonly defined as 
cessation of breathing for >20 s, or >10 s with associated bra-
dycardia or oxygen desaturation (5). In our research, we use 
the abbreviation ABDn for episodes of central apnea of at least 
n seconds duration, when accompanied by both bradycardia 
and desaturation (6). Hypoxia associated with apnea could 
have detrimental effects on developing tissues and organs 
resulting in long-term or permanent impairment (6–10), and 
therapies such as respiratory support and caffeine are only 
partially successful in reducing the burden of AOP (11,12). 
Management of refractory apnea, optimum levels and dura-
tions of various therapies, and determining readiness for dis-
charge from the neonatal intensive care unit (NICU) continue 
to be major challenges, and accurate quantitation of apnea is 
required for both clinical care and outcomes research (13).
Quantitation of apnea in NICU patients has historically 
involved one of two approaches: medical record documenta-
tion of events by bedside caregivers, or short pneumographic 
recordings of respiratory impedance or inductance signals, 
heart rate, and oxygen saturation. These approaches are lim-
ited, the former by inaccuracy of reporting (14–16) and the 
latter by requirements for extra attachments to infants and 
time and expertise required for signal interpretation. As a 
result, previous studies of AOP are limited by small numbers of 
infants studied over short periods of time. Our group recently 
developed a novel automated computer algorithm for quanti-
fying central apnea of prematurity from waveform and vital 
sign data continuously collected from standard NICU bed-
side monitors (17). This system was clinically validated and 
allows identification of central AOP events in large numbers of 
infants for the entire NICU stay.
Clinical variables affecting the severity of AOP and the tim-
ing of resolution as infants approach term-corrected age are 
not well defined. Prior studies have shown an inverse correla-
tion between gestational age at birth and postmenstrual age 
at which apnea resolves (18–20). Chronic or acute pathologic 
processes may also impact the occurrence, severity, and dura-
tion of AOP. For example, severe intraventricular hemor-
rhage (IVH) may be associated with central nervous system 
dysfunction that could manifest as central apnea (6,21,22), 
and bronchopulmonary dysplasia, with associated abnormal 
blood oxygen and carbon dioxide levels, may be associated 
with dysregulation of peripheral or central chemoreceptor 
sensitivity and increased apnea. Acute systemic inflamma-
tory processes such as sepsis are known to lead to an abrupt 
increase in apnea over baseline in some infants (23,24). It is 
also possible that hypoxemia association with AOP may con-
tribute to pathology such as retinopathy of prematurity (8,10) 
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or might contribute to neurodevelopmental impairment 
(7,10,25).
The goals of the current study were twofold: to provide a 
comprehensive assessment of the burden of central apnea 
throughout the NICU stay of a large number of preterm 
infants, and to establish the association of AOP with chronic 
and acute pathologic processes.
RESULTS
Demographics, Clinical Outcomes, and Respiratory Support
Of 1,372 infants <35 wk gestation admitted to the UVA NICU 
during the study period, chest impedance waveform and vital sign 
data were available for analysis for 1,268. Figure 1 shows the type 
of respiratory support for each infant relative to gestational age 
(GA) and postmenstrual age (PMA). Fifty-seven of these infants 
were excluded from the apnea, with bradycardia and desatura-
tion (ABD), analysis because they had no chest impedance data 
off mechanical ventilation and prior to 40 wk PMA, either due 
to death or transfer from our unit. Demographics and clinical 
outcomes of the 1,211 infants with ABDs analyzed are shown in 
Table 1. Median gestational age for the entire cohort was 32 wk 
(25th-75th% 28–33 wk). Birthweight distribution was 235 (19%) 
extremely low birth weight (<1,000 g) and 521 (43%) very low 
birth weight (<1,500 g).
Number of ABDs Is Inversely Correlated With GA and PMA
ABD events were assessed when chest impedance, heart rate, 
and SpO2 data were available and infants were not on mechani-
cal ventilation including nasal intermittent positive pressure 
ventilation. Median number of days analyzed per infant was 15 
(25th-75th percentile 7–34 d, > 50 infant-years of data).
Figure 2a shows an example of an algorithm-detected 
ABD10 event, with the major features described in the caption. 
Figure 2b is a histogram showing the number of infants in each 
GA week with at least one ABD10 event during the NICU stay. 
Percentage of infants with at least one algorithm-detected ABD 
based on GA group is as follows: 97% of infants <27 wk, 92% of 
infants 27–30 wk, 73% of infants 31–32 wk, and 52% of infants 
33–34 wk. Note that some infants with no detected ABDs may 
have been on prolonged mechanical ventilation or may have 
been transferred to our center at later PMAs for procedures.
Figure 3 includes two heat maps of the average daily number 
of ABD events for all 1211 infants based on GA and PMA, with 
ABD10 and ABD20 shown (3A, 3B). Note that ABD20 events 
(apnea at least 20 s with associated bradycardia <100 and 
desaturation <80% of any duration) are a subset of the ABD10 
events. In these heat maps, warmer colors denote more apnea 
events each day, and are most evident in the lower left hand 
corners—lower GA and PMA. ABD10s persist to later PMAs 
compared to ABD20s—for example, the average number of 
ABD10s at 34 wk PMA is 3 or more, while there is on average 
<1 ABD20 at 34 wk PMA. The inset of Figure 3a shows that 
the number of ABD10s at 32–36 wk PMA is about threefold 
greater for infants <31 wk GA compared to those 31–34 wk. 
Among the infants <31 wk GA, however, there is no significant 
impact of GA on the number of ABD10 at these later PMAs.
Figure 1. respiratory support. Type of respiratory support over the 
course of the neonatal intensive care unit stay is shown for all 1,268 infants 
<35 wk gestational age (GA) with bedside monitor data available for analy-
sis. Number of infants in each GA week group is shown on the right y axis, 
and the change in color represents mode of respiratory support with 
advancing postmenstrual age: ventilator (black), nasal continuous positive 
airway pressure (green), nasal cannula (NC, yellow), and room air (blue).
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table 1. Characteristics and outcomes of 1,211 infants with ABDs analyzed
<27 wk (n = 190) 27–30 wk (n = 297) 31–34 wk (n = 724)
Gestational age weeks 25 (24–26) 29 (28–30) 33 (32–34)
Birth weight (g) 750 (640–850) 1,200 (1,020–1,440) 1,950 (1,670–2,270)
Death before NICU discharge 7 (3.7%) 5 (1.7%) 7 (1.0%)
Severe IVH (Grade III-IV) 34 (16%) 10 (3.4%) 3 (0.4%)
Late-onset septicemia 62 (29%) 24 (8.1%) 9 (1.2%)
Necrotizing enterocolitis 16 (7%) 16 (5.4%) 9 (1.2%)
Bronchopulmonary dysplasiaa 119/175 (68%) 72/283 (25%) 26/719 (3.6%)
Treated retinopathy of prematurityb 42 (22%) 4 (1.3%) 0
Discharged home 145 (68%) 244 (77%) 650 (88%)
Postmenstrual age at d/c home 39 (37–41) 36 (35–38) 35.5 (35–36)
Data presented as median (25th-75th%ile) or n (%).
aDenominator is number for whom outcome at 36 wk postmenstrual age is known. bLaser or bevacizumab.
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Figure 2. apnea, bradycardia, desaturation example, and incidence. Apnea at least 10 s with associated bradycardia <100 beats/min and oxy-
gen desaturation <80% were analyzed using a published algorithm (17). (a) Graphic representation of 60 s of vital sign and waveform data showing 
a representative ABD event. From top to bottom: Heart rate (HR with 100 beats per minute threshold of bradycardia indicated by the thin green 
line), oxygen saturation (SpO2 with 80% threshold of desaturation indicated by the thin blue line), chest impedance (CI), filtered chest impedance 
(FCI), and computer algorithm-detected probability of apnea (PA). An “ABD10” event is shown, with apnea duration >10 seconds and associated 
bradycardia and oxygen desaturation. Another shorter breathing pause occurred without associated bradycardia, which did not meet our definition 
of an “ABD” event. (b) ABDs were analyzed on all infants all times that bedside monitor data were available and the infant was not on mechanical 
ventilation. Number of infants of each gestational age with at least one algorithm-detected ABD10 event (black fill) and with no events detected 
(white) is shown.
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Figure 3. Mean number of aBd events per day based on gestational and postmenstrual age. For 1,211 infants <35 wk gestational age (GA), ABDs 
were analyzed during all times that data were available and infants were not on mechanical ventilation. (a) Heat map of mean daily #ABD10s (apnea 
at least 10 s with associated bradycardia and desaturation) for each week of GA and postmenstrual age (PMA). Color scale goes from blue (zero) to red 
(eight) events per day. The line graph below shows mean daily #ABD10s for infants <27 wk GA (blue), 27–30 wk (green), and 31–34 wk (red). (b) Mean daily 
#ABD20s (apnea at least 20 s with bradycardia and desaturation) for each week of GA and PMA.
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Lack of Association of Number of ABDs With Severe ROP, BPD, 
and Severe IVH
Since retinopathy of prematurity (ROP) has been linked to 
aberrant oxygenation (8,26,27), and since apnea is a major 
cause of hypoxia (28,29) and rebound hyperoxia (30), we 
tested the hypothesis that the number of ABD events would be 
greater in infants who developed severe ROP requiring laser 
or bevacizumab therapy (Supplementary Figure S1 online). 
After accounting for GA, we did not find a statistically signifi-
cant difference in the mean number of ABD10s throughout the 
NICU stay in 47 infants with treated ROP compared to those 
without (Supplementary Figure S1a online). We also analyzed 
ABDs in infants with and without severe IVH (grade III-IV) 
and in those with BPD, since both of these conditions might be 
thought to lead to increased frequency of apnea. Considering 
all ABD10 events throughout the NICU stay, after account-
ing for GA, there was no significant difference in number of 
apnea events in the 243 infants with BPD or the 51 infants with 
severe IVH (Supplementary Figure S1b,c online) compared 
to infants without these morbidities. We further investigated 
whether, at later PMA when infants are maturing and nearing 
NICU discharge, infants with BPD or severe IVH have more 
central apnea spells with bradycardia and desaturation than 
those without. At 35 wk PMA, we found that GA is signifi-
cantly associated with BPD and severe IVH (ROC AUCs 0.927 
and 0.817, respectively, P < 0.0001), but that after accounting 
for GA infants with BPD did not have more ABD10s at 35 wk 
PMA compared to babies without BPD, (ROC AUC 0.927, 
change in AUC 0, P = 0.63). For babies with severe IVH, there 
was a trend toward more ABDs at 35 wk PMA that was not sta-
tistically significant (ROC AUC 0.832, change in AUC 0.015, 
P = 0.085).
Apnea Increases Before Diagnosis of Late-Onset Septicemia 
and necrotizing enterocolitis (NEC)
Acute systemic inflammatory processes can be associated with 
apnea in preterm infants (23), and we therefore analyzed ABDs 
in these illnesses (Supplementary Figure S2 online). We iden-
tified 28 cases of late-onset septicemia and 21 cases of NEC 
in infants when they were not on mechanical ventilation and 
had chest impedance and vital sign data available for analy-
sis >50% of the time in the 48-h period prior to diagnosis. In 
seven cases of NEC (33%) and 12 cases of late-onset septicemia 
(43%) infants had at least twofold increased ABD events in the 
24-h period prior compared to 24–48 h prior to diagnosis. We 
also analyzed number of seconds of apnea associated with bra-
dycardia and desaturation in the 24 h period before diagnosis 
compared to 24–48 h prior, and found similar results as shown 
in Supplementary Figure S2 online.
ABD Events in the Week Prior to Discharge Home From the NICU
We sought to determine whether infants continued to expe-
rience mild, self-resolved or not clinically recognized ABD 
events in the week prior to NICU discharge. Of the 1,211 
infants included in this analysis, 1,048 were discharged home 
(the others either died or were transferred to another unit). 
Decisions about readiness for discharge were made by the 
clinical care team without knowledge of algorithm-detected 
ABDs. Caffeine was usually discontinued between 32–34 wk 
PMA, when the infant was off continuous positive airway pres-
sure and no longer having significant clinically detected apnea 
events requiring stimulation. In our unit during the period of 
this study, there was a general policy of an 8-d “apnea count-
down” with no events requiring intervention before discharge 
home (18). Minor apnea events that are self-resolved or that 
occur during feeding generally do not delay discharge, and 
events that occur following immunizations or general anesthe-
sia near the time of NICU discharge do not restart the apnea 
countdown. Cardiorespiratory monitors are routinely pre-
scribed for infants going home on supplemental oxygen and 
are occasionally prescribed for other infants with clinical con-
ditions or events at the discretion of the medical team.
PMA for the 1,048 infants discharged home was 36.6 ± 2.7 wk. 
In the 7 d prior to discharge, no ABD10s were detected by the 
automated algorithm in 508 infants (48%), whereas 146 infants 
(14%) had 10 or more events (Table 2). GA was significantly 
lower in infants with ABDs in the week before discharge, but 
PMA at discharge was similar for infants with and without dis-
charge week ABDs. A home apnea monitor or pulse oximeter 
or both were prescribed at discharge for 168 infants (16%), 
including all infants discharged on supplemental oxygen and 
58 infants discharged on room air. Fourteen infants not on 
supplemental oxygen and with no ABDs detected by our algo-
rithm in the week prior to discharge were sent home with a 
monitor, while 103 babies with more than 10 ABDs detected in 
the week prior to discharge were sent home without a monitor.
table 2. ABD10s in the week before discharge home
No ABDs (n = 508) 1–10 ABDs (n = 394) >10 ABDs (n = 146) P = *
Gestational age (weeks) 33 (31–34) 31 (28–31) 30 (27–31) <0.001
Discharge PMA (weeks) 36 (35–37) 36 (35–38) 36 (35–38) 0.45
No monitora at discharge 460 (91%) 319 (81%) 103 (71%) <0.001
Oxygen and monitor at discharge 34 (6.7%) 51 (13%) 24 (16%) <0.001
Monitor, no oxygen at discharge 14 (2.8%) 24 (6.1%) 19 (13%) <0.001
Readmitted for apnea or apparent life-threatening eventb 4 (0.8%) 7 (1.8%) 4 (2.7%) 0.71
Median (25th-75th%) or n (%).
* ≥1 ABD vs. no ABD.
aApnea monitor or pulse oximeter. bAdmitted to UVa Hospital within 8 wk of UVa NICU discharge.
IVH, intraventricular hemorrhage; NICU, neonatal intensive care unit; PMA, postmenstrual age.
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Apparent Life-Threatening Event and sudden infant death 
syndrome
As shown in Table 2, (15) infants were readmitted within 8 wk 
of NICU discharge for apnea or apparent life-threatening event, 
including 2% of infants with one or more discharge week ABDs 
and 0.8% of infants with no discharge week ABDs (P = 0.17).
Reviewing matched birth/death records from the state of 
Virginia, we found one sudden infant death syndrome death 
in the study population. The infant was a 32 wk GA twin dis-
charged at 35 wk PMA who died 2 wk after NICU discharge 
with a forensic autopsy identifying cause of death as sudden 
infant death syndrome. As we previously reported, during her 
3 wk in the NICU, she had excessive periodic breathing—five-
fold more than other 32 wk infants—but no clinically recorded 
apnea and only one computer-detected ABD10 event, which 
did not occur in the week prior to discharge (31).
DISCUSSION
We provide a quantitative analysis of central apnea through-
out the NICU stay of 1,211 preterm infants that confirms some 
old concepts about AOP and challenges others. We found, as 
expected, that apnea accompanied by both bradycardia and 
oxygen desaturation is common in the NICU despite respi-
ratory and pharmacologic treatments administered to nearly 
all very preterm infants. We confirmed that an acute increase 
in ABD events may occur in the day prior to diagnosis of an 
acute illness such as sepsis or NEC. On the other hand, chronic 
pathologic processes (ROP, BPD, IVH) were not significantly 
associated with the frequency of central apnea after control-
ling for gestational age. Finally, we found that longer apneas 
(ABD20s) resolve earlier than shorter ones, and ABD10 events 
are not uncommon in the week prior to NICU discharge of 
healthy preterm infants.
Limitations of the Automated Apnea Detection System
Our apnea detection algorithm requires low or absent variance 
in the chest impedance signal to detect cessation of breathing 
efforts, and thus detects only central apnea. Preterm infants 
also have obstructive apnea, which may or may not be accom-
panied by some degree of motion of the chest wall and abdo-
men. The algorithm filters out gross motion artifact before 
identifying breathing signals in the impedance waveform, but 
it was not designed to identify obstructive apnea. Prior studies 
using measures of nasal airflow (thermistors or carbon dioxide 
detectors) and respiratory inductance plethysmography indi-
cate that the majority of apnea events in preterm infants have 
both central and obstructive components. Our methodology 
will miss pure obstructive events but will capture pure central 
and most mixed central/obstructive events.
We employed a stringent definition of apnea, requiring 
both bradycardia and oxygen desaturation, in order to mea-
sure the most clinically significant events. Many other stud-
ies, and the NICHD Consensus Statement (5), define AOP as 
cessation of breathing with bradycardia or desaturation and 
give slightly different thresholds for “BD”. Also, the algorithm 
detects ABD events irrespective of whether they are noticed 
or are considered clinically important. We previously reported 
that medical record documentation does not accurately reflect 
occurrence of ABD events (14), and speculate that many of 
the algorithm-detected events are self-resolved or are occur-
ring during or following procedures, handling, or feeding and 
therefore not necessarily documented by bedside caregivers.
Finally, we are reporting only on the number of ABD events, 
thus we do not make any statements about depth or duration 
of bradycardia or oxygen desaturation.
Apnea Prior to Diagnosis of Acute Illness
An acute increase in apnea is generally thought to reflect 
acute stress or illness in preterm infants, and our study pro-
vides quantitative evidence of this. Apnea during septicemia 
or NEC is likely attributable at least in part to release of pros-
taglandins during a systemic inflammatory response (32–34). 
Many infants did not experience an increase in apnea during 
sepsis or NEC and we do not have enough cases to determine 
whether apnea is more likely to occur with specific organisms 
or reflects a higher severity of illness. Future work will focus 
on whether real-time analysis and display of abnormal respira-
tory or other vital sign patterns could provide early warning of 
potentially catastrophic illnesses, leading to earlier treatment 
and improved outcomes.
Lack of Association of Apnea Frequency and Chronic Morbidities
After accounting for gestational age, we did not find a greater 
number of ABD events among infants with severe ROP. Large 
randomized clinical trials have demonstrated that targeting 
lower SpO2 results in lower rates of ROP (27) but a smaller ret-
rospective study suggested that intermittent hypoxia events are 
linked to more severe ROP (8). It is likely that retinal vascu-
lar pathology is related to both hyperoxia and hypoxia and to 
the phase of development at which aberrant SpO2 occurs. We 
did not analyze the timing, depth, or duration of hypoxia dur-
ing apneic events, nor did we assess hypoxia occurring with-
out central apnea (35). Most of our infants with severe ROP 
were ≤25 wk GA and were on prolonged mechanical ventila-
tion, which precludes apnea but does not preclude dysoxia that 
might contribute to ROP.
The finding that infants with BPD did not have more cen-
tral apnea was surprising, since chemoreceptor dysregulation 
might be expected in these infants (3). It is possible that infants 
with significant lung disease are on mechanical ventilation or 
other respiratory support and caffeine for prolonged periods of 
time when they are most susceptible, and thus apnea is masked. 
Infants with BPD may also be more prone to obstructive apnea 
(28,36,37) which we did not measure. Other studies review-
ing apnea or bradycardia events documented in the medical 
record have reported more events in very preterm infants with 
BPD (19,20).
We did not find a significant difference in number of ABDs 
in infants with severe IVH though there was a trend toward 
slightly more ABDs at later PMA. The number of infants 
with high-grade IVH in our cohort was small, and we did not 
separately analyze the even smaller fraction of infants with 
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posthemorrhagic hydrocephalus who might have more apnea. 
Additionally, our methods did not allow us to assess whether 
infants with IVH had more obstructive apnea as has been 
reported by others (21). Larger studies would be required to 
determine whether, as has been reported in a small study, pre-
discharge apnea predicts adverse neurodevelopment at several 
years of age in preterm infants with severe IVH (9).
Resolution of Apnea
We found, consistent with other reports (18–20,23), that infants 
born at gestations <31 wk had apnea to later PMA than those 
born less preterm. This reaffirms that a specific PMA (e.g., 36 wk) 
cannot be used as a “safe” benchmark for low apnea risk without 
also considering GA. In the spectrum from 23–31 wk GA, how-
ever, our data show that the number of ABD events by the time 
infants reached 35 wk PMA was no longer a function of GA at 
birth. This is in contrast to findings of other studies (19,20) that 
relied on medical record documentation of events and therefore 
probably captured more events that required intervention and 
were considered clinically important. These studies also included 
bradycardia or apnea episodes and thus likely included obstruc-
tive apnea and vagal bradycardia which we did not measure.
Many infants in our cohort who were otherwise ready for 
discharge home continued to have short algorithm-detected 
ABDs. These events may have been self-resolved or occurred 
during feeding or stressors such as immunization (38), Most 
infants were sent home without a monitor and very few were 
readmitted to our hospital within 2 mo for apnea or appar-
ent life-threatening event, which is in keeping with other 
reports (39). Our unit protocol of discharging infants after a 
week free of needing stimulation to resolve an apneic spell has 
not changed based on our studies to date, and further work 
in larger patient populations is needed to establish criteria for 
safe NICU discharge, since the cost of additional hospital days 
simply for an “apnea countdown” is substantial (40).
Conclusion
Apnea events with associated bradycardia and oxygen desatu-
ration occur frequently in hospitalized preterm neonates in 
spite of respiratory support and caffeine. Further research is 
needed to determine the long-term impact of these events and 
identify therapies to minimize apnea burden in the NICU.
METHODS
Study Population and Data Collection
We stored and analyzed the bedside monitor waveforms and vital signs 
of all infants <35 wk gestation in the University of Virginia NICU from 
January 2009 through March 2014. The study was approved by the 
UVA Institutional Review Board as requiring no consent, since all data 
were analyzed retrospectively and could not influence patient care.
Demographic and clinical data, including dates on and off mechani-
cal ventilation and other respiratory support, were obtained from the 
electronic medical record. Clinical decisions were made by the care team 
without knowledge of computer algorithm-detected apneas. Caffeine 
was given based on our unit policy of initiating caffeine for all infants 
<32 wk GA at birth, and discontinuing caffeine after 32 wk postmen-
strual age once the infant was off continuous positive airway pressure 
and having little or no clinically recognized apnea requiring stimula-
tion. Decisions about dosing and duration of caffeine and readiness for 
discharge home were based on standard assessment of bedside moni-
tor data, medical record documentation, and nursing reports of apnea 
events. Generally in our unit during the years of this study, an 8-d period 
free of apnea requiring stimulation was required prior to discharge (18).
Clinical events and conditions were recorded in a relational clinical 
database. Severe IVH grade III-IV was identified by serial head ultra-
sounds. BPD was defined as requirement for supplemental oxygen in 
our NICU at 36 wk postmenstrual age. Infants who were transferred 
to an outside hospital on oxygen prior to 36 wk PMA and for whom 
the subsequent oxygen status was not known were not included in the 
BPD analysis. Late-onset septicemia was defined as signs of sepsis >3 
d from birth, positive blood culture, and antibiotic treatment for at 
least 5 d. Diagnosis of NEC required abdominal signs with abdominal 
radiograph showing pneumatosis, portal venous air, or pneumoperi-
toneum, or requirement for surgery. Cases of NEC with associated 
septicemia were classified as NEC alone. Severe ROP was defined as 
requiring laser photoablation or intravitreous bevacizumab therapy.
Data Analysis
Development and validation of the apnea detection system used in this 
study were previously reported (17). Bedside monitor data were col-
lected using a central network server (BedMaster Ex, Excel Medical, 
Jupiter, FL), including chest impedance waveforms (60 Hz), electro-
cardiogram waveforms (three leads at 240 Hz each), and every 2 s oxy-
gen saturation from pulse oximetry signals (using 8 s SpO2 averaging). 
A computer algorithm was developed to detect episodes of low vari-
ance in the chest impedance waveform signal after eliminating heart 
beat and motion artifact. Temporally associated declines in heart rate 
to less than 100 bpm and in oxygen saturation to less than 80% were 
identified. The algorithm identified ABDn events as central apnea of at 
least n seconds with both bradycardia and desaturation of any dura-
tion. For example, ABD10 denotes an episode of cessation of chest 
movement of 10 or more seconds with associated bradycardia <100 
bpm of any duration and desaturation <80% of any duration. The algo-
rithm underwent extensive development, testing, and validation (17).
Statistical Analysis
Continuous variables were analyzed by t-test or ANOVA and categorical 
variables by Fischer exact test. Receiver operator characteristics curves 
were constructed, and change in ROC area was analyzed to determine 
the impact of GA, severe IVH, and BPD on number of ABD events at 
35 wk PMA. Number of ABDs in the day prior to septicemia or NEC 
diagnosis was compared to the prior 1-d baseline for each infant by sign 
rank test. Statistical significance was considered as two-tailed P < 0.05, 
and analyses were conducted in MATLAB (MathWorks, Natick, MA)
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